The temporary rule on the sale of controlled drugs in RS comes to an end

News Healthcare & Pharma Law & Policy Updates

Date: 7th Nov, 2024 Source: National Health Surveillance Agency (Anvisa) Country: Brazil Original Source

Brief

On November 8, 2024, the National Health Surveillance Agency (Anvisa) reiterated that the temporary receipt model indicated in Resolution RDC 864/2024 should no longer be used. The deadline for this rule, established due to the public calamity in RS, has expired, and all prescriptions for controlled medicines subject to Notifiable Receipt must now be made using official forms, as done nationwide.

This content is restricted.

Highlights content goes here...

This content is restricted.

National Health Surveillance Agency (Anvisa)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

The temporary rule on the sale of controlled drugs in RS comes to an end

Brief

National Health Surveillance Agency (Anvisa)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

The temporary rule on the sale of controlled drugs in RS comes to an end

Brief

National Health Surveillance Agency (Anvisa)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.